Fubotv earnings beat by $0.10, revenue topped estimates
Therapeutic Solutions International, Inc. (OTC Markets:TSOI), a micro-cap company with a market value of $1.54 million specializing in medical instruments and apparatus, has declared a one-time loyalty dividend for its shareholders. The announcement was made on February 15, 2025, with the dividend involving shares in subsidiary Breathe Biologics, Inc. (BRTH). According to InvestingPro data, the company typically does not pay regular dividends to shareholders, making this a unique development.
Shareholders of Therapeutic Solutions as of market close on March 3, 2025, are eligible to receive the dividend. The conversion rate stipulated is 0.001293129082553 shares of BRTH for every share of TSOI held. The company, owning 86.53% or 22,500,000 shares of BRTH, will distribute 7,500,000 shares from its holdings to its shareholders. InvestingPro analysis reveals the company's challenging financial position, with a current ratio of 0.27 and a weak overall Financial Health Score of 1.72.
The dividend offer will remain open for 60 days, starting from the Dividend Offer Date until May 3, 2025. Following the closure of the offer period, on May 3, 2025, Therapeutic Solutions will issue a second 8-K with instructions and forms for shareholders who elect to receive the dividend. Shareholders will be required to provide a brokerage statement confirming their TSOI shareholding on March 3, 2025, to claim their dividend.
This strategic move by Therapeutic Solutions aims to reward its loyal shareholders with a stake in its subsidiary, Breathe Biologics, which operates in the same sector. The dividend issuance process will be documented through a Book Entry Statement to be provided to shareholders upon the completion of the necessary forms and verification of holdings.
This comes as the company faces significant challenges, with InvestingPro data showing a 72.73% decline in share price over the past year and revenue of just $0.09 million in the last twelve months.
This information is based on a press release statement and the details of the loyalty dividend distribution are subject to the terms outlined in the company's SEC filings.
In other recent news, Therapeutic Solutions International, Inc., a Nevada-based medical device company, has expanded its authorized shares. The firm made a notable amendment to its corporate charter, which has increased the total authorized shares from 6.5 billion to 9 billion. The amendment also retains the 5 million authorized preferred shares at a par value of $0.001 each.
This decision was made through a nonunanimous majority written consent of stockholders, with board members Timothy G. Dixon and Thomas E. Ichim, who are also Series A Preferred stockholders, consenting in favor of the amendment. Their consent carries significant weight as Series A Preferred stockholders have substantial voting power.
While the specific reasons for this increase in authorized shares were not disclosed, it is understood that they could potentially be used for various corporate purposes, including financing company operations, expansion, or acquisitions. These are recent developments within the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.